Product Categories
Country: | China |
---|---|
Tel: | |
Mobile: | 15002134094 |
E-mail: | marketing@targetmol.cn |
QQ: | 2881954871 |
Skype: | Chat Now! |
Product Name | MF | CAS | Details |
---|
Cudarolimab | 2244739-29-3 | Details |
BI-10 | C23H17BrN2O | 2759037-58-4 | Details |
Bafrekalant | C29H31ClN6O2 | 2256770-44-0 | Details |
Pafenolol | C18H31N3O3 | 75949-61-0 | Details |
Gly-Arg-Gly-Asp-Ser TFA | C17H30N8O9.C2HF3O2 | 2828433-23-2 | Details |
Vinaxanthone | C28H16O14 | 133293-89-7 | Details |
Ontazolast | C21H25N3O | 147432-77-7 | Details |
Regorafenib mesylate | C22H19ClF4N4O6S | 835621-08-4 | Details |
BMS-566419 | C28H30FN5O2 | 566161-24-8 | Details |
PTP1B-IN-15 | C19H17Br2NO5S | 765317-71-3 | Details |
SARS-CoV-2 nsp13-IN-1 | C27H20N4O2 | 1005304-44-8 | Details |
Tampramine | C23H24N4 | 83166-17-0 | Details |
DG013A | C27H37N4O4P | 2007955-07-7 | Details |
TXA6101 | C18H10BrF5N2O3 | 1459695-66-9 | Details |
GNF2133 hydrochloride | 2561414-57-9 | Details |
Ciproquazone | C19H18N2O2 | 33453-23-5 | Details |
Minamestane | C19H23NO2 | 105051-87-4 | Details |
A2A receptor antagonist 3 | C26H26N6O2 | 2738606-83-0 | Details |
ITK inhibitor 6 | C28H24F2N4O2 | 2404604-06-2 | Details |
Tau-aggregation and neuroinflammation-IN-1 | C25H20N2O7 | 2175953-98-5 | Details |
HAMI 3379 | C34H45NO8 | 1245653-57-9 | Details |
Methyl 3-(3-bromophenyl)-1,2-oxazole-5-carboxylate | C11H8BrNO3 | 377059-68-2 | Details |
BS-181 dihydrochloride | C22H33ClN6 | 1883548-83-1 | Details |
RIPK3-IN-1 | C29H25FN4O4 | 2361139-70-8 | Details |
MK-8153 | C24H28N2O6 | 1548286-45-8 | Details |
Paltimatrectinib | C20H15F5N6 | 2353522-15-1 | Details |
Fadrozole HCl hydrate | C28H30Cl2N6O | 176702-70-8 | Details |
Inaperisone | C16H23NO | 99323-21-4 | Details |
Oxepinac | C16H12O4 | 55689-65-1 | Details |
DDO-02005 | C21H26ClN3O2 | 1186049-44-4 | Details |
Clevudine triphosphate | O10P3-5 | 174625-00-4 | Details |
Tripelennamine citrate | C22H29N3O7 | 6138-56-3 | Details |
ONO-9780307 | C30H35NO7 | 856691-44-6 | Details |
ZINC09659342 | C23H15F3N2O4 | 1668604-47-4 | Details |
Ezurpimtrostat hydrochloride | C25H32Cl2N4 | 1914148-73-4 | Details |
CSF1R-IN-3 | C30H38N8O4 | 2760584-90-3 | Details |
Camonagrel | 105920-77-2 | Details |
Human IgE Pentapeptide HEPP acetate | Details |
MK-6186 | C21H12Cl2N6O | 1034474-19-5 | Details |
PND-1186 hydrochloride | C25H27ClF3N5O3 | 1356154-94-3 | Details |
Darglitazone Sodium | C23H20N2O4S.Na | 149904-87-0 | Details |
ST247 | C19H26N2O5S2 | 1356497-91-0 | Details |
BACE-IN-1 | C22H16ClN5O2 | 1254166-60-3 | Details |
IXA6 | C22H20ClN3O3S | 1021106-40-0 | Details |
Nezulcitinib | C30H37N7O2 | 2412496-23-0 | Details |
Cadonilimab | 2394841-59-7 | Details |
Elbanizine | C26H31N5O2 | 110629-41-9 | Details |
Safironil | C15H23N3O4 | 134377-69-8 | Details |
UCB7362 | C25H26ClN5O3 | 2610631-17-7 | Details |
Annamycin | C26H25IO11 | 92689-49-1 | Details |
Epitinib | C24H26N6O2 | 1203902-67-3 | Details |
Efpeglenatide | 1296200-77-5 | Details |
(Rac)-Norcisapride | C14H20ClN3O3 | 84946-16-7 | Details |
NDB | C26H28Cl2N2O2 | 1660153-08-1 | Details |
ALDH2 modulator 1 | C18H18ClFN2O3 | 1629615-99-1 | Details |
Org 43553 | C24H30N6O3S2 | 501444-88-8 | Details |
(16aR)-1,16-Bis(diphenylphosphino)-6,7,8,9,10,11-hexahydrodibenzo[b,d][1,6]dioxacyclododecine | C42H38O2P2 | 301847-92-7 | Details |
6-Oxohexyl 2-hexyldecanoate | C22H42O3 | 1849616-54-1 | Details |
Pipoxizine | C24H31NO3 | 55837-21-3 | Details |
Tiflucarbine | 89875-86-5 | Details |
740 Y-P acetate | Details |
UNC4203 | C30H44N6O | 1818234-19-3 | Details |
Glucametacine | C25H27ClN2O8 | 52443-21-7 | Details |
Nrf2 activator-4 | C23H23F3N2O3.ClH | 2383016-68-8 | Details |
PI3K/mTOR Inhibitor-4 | C27H22FN3O6S | 2361215-32-7 | Details |
UCM-1306 | C14H14FNO2S | 2258608-78-3 | Details |
LabMol-319 | C22H16N2O5 | 381188-63-2 | Details |
Duocarmycin analog-2 | C29H23ClN4O3 | 1164275-01-7 | Details |
MCT1-IN-3 | C22H19N3O4 | 2878360-80-4 | Details |
Mytoxin B | C29H36O9 | 105049-15-8 | Details |
BRL-15572 hydrochloride | C25H28Cl2N2O | 1173022-77-9 | Details |
Ac-DEVD-CHO acetate | C20H30N4O11 | Details |
(15aS)-1,15-Bis(diphenylphosphino)-7,8,9,10-tetrahydro-6H-dibenzo[b,d][1,6]dioxacycloundecine | C41H36O2P2 | 486429-95-2 | Details |
CJ-2360 | C27H30FN5O2 | 2226742-61-4 | Details |
Solpecainol | C18H23NO3 | 155321-96-3 | Details |
Rociclovir PM | C9H13N5O3 | 89419-23-8 | Details |
CDK5-IN-2 | C29H28FN5O | 2639542-22-4 | Details |
Tubulin inhibitor 23 | C26H23NO6S | 170488-57-0 | Details |
Saterinone | C27H30N4O4 | 102669-89-6 | Details |
NF-κB/MAPK-IN-1 | C27H27NO7 | 2413940-56-2 | Details |
CCT369260 | C24H31ClF2N6O2 | 2647503-57-7 | Details |
ML138 | C19H14Cl2N4OS | 1355243-24-1 | Details |
18-Deoxyherboxidiene | C25H42O5 | 1200128-66-0 | Details |
(15aR)-1,15-Bis(diphenylphosphino)-7,8,9,10-tetrahydro-6H-dibenzo[b,d][1,6]dioxacycloundecine | C41H36O2P2 | 301847-91-6 | Details |
4,4'-(Triaz-1-ene-1,3-diyl)dibenzimidamide hydrochloride | C14H16ClN7 | 2331268-15-4 | Details |
GSK2647544 | C24H18ClF3N4O3 | 1380426-95-8 | Details |
Edecesertib | C22H22FN7O2 | 2408839-73-4 | Details |
BSJ-01-175 | C30H33ClN6O2 | 2227392-55-2 | Details |
Losulazine | C27H22F4N4O3S | 72141-57-2 | Details |
CQ211 | C26H22F3N7O2 | 2648986-65-4 | Details |
Glyoxalase I inhibitor 2 | C24H23N3O4S | 2314467-61-1 | Details |
SMO-IN-3 | C27H25F4N3O2 | 2376914-71-3 | Details |
10-Formyl-5,8-dideazafolic acid | C22H21N5O7 | 61038-31-1 | Details |
Laniquidar | C37H36N4O3 | 197509-46-9 | Details |
ABC44 | C31H40N6O5 | 1831135-46-6 | Details |
Vamotinib | C29H27F3N6O | 1416241-23-0 | Details |
Xanthine amine congener hydrochloride | C21H29ClN6O4 | 1783977-95-6 | Details |
BTA-188 | C21H28N4O2 | 314062-80-1 | Details |
Tazomeline | C14H23N3S2 | 131987-54-7 | Details |
GS-6620 PM | C13H15N5O4 | 1191237-49-6 | Details |
Product Total: Product Page: | ||||
59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 |